fincash logo SOLUTIONS
EXPLORE FUNDS
CALCULATORS
LOG IN
SIGN UP

Fincash » Search » GlaxoSmithkline Consumer Healthcare Ltd

GlaxoSmithkline Consumer Healthcare Ltd

Updated on January 15, 2020

Stock/Share Code - GSKCONS

GlaxoSmithkline Consumer Healthcare is engaged in manufacturing and sale of healthcare consumer products.(Source : 201903 Annual Report Page No: 52)

Below is the details of GSKCONS GlaxoSmithkline Consumer Healthcare Ltd

Market Cap₹37,209 Cr.
Current Price ₹8,716 as on 10 Dec 19
52 Week High / Low Price₹9,387.7 / ₹6,856.05
Face Value₹10
Stock P/E33.82
Book Value₹989.59
Dividend Yield1.19 %
ROCE39.91 %
ROE25.92 %
Sales Growth (3yrs)4.95 %
SectorFMCG
IndustryFood - Processing - MNC
Listed onBSE  AND  NSE
Company WebsiteCompany Website
Pros: Company is virtually debt free. Company has been maintaining a healthy dividend payout of 44.94%
Cons: Stock is trading at 8.94 times its book value The company has delivered a poor growth of -0.36% over past five years. Earnings include an other income of Rs.451.85 Cr.

GlaxoSmithkline Consumer Healthcare Ltd Price Chart

GlaxoSmithkline Consumer Healthcare Ltd Price Chart

GlaxoSmithkline Consumer Healthcare Ltd Peer Comparison in FMCG

S.No. Name CMP Rs. P/E Mar Cap Rs.Cr. Div Yld % NP Qtr Rs.Cr. Qtr Profit Var % Qtr Sales Var % Sales Qtr Rs.Cr. ROCE %
1. Nestle India ₹14,091.7 75.81 ₹139,358.79 Cr. 0.80 ₹595.41 Cr. 33.47 9.41 3215.81 70.93
2. Britannia Inds. ₹3,059.35 58.18 ₹73,527.99 Cr. 0.49 ₹404.22 Cr. 33.71 6.25 3048.84 44.31
3. GlaxoSmith C H L ₹114.35 33.82 ₹37,209.22 Cr. 1.19 ₹345.31 Cr. 25.34 5.75 1345.09 39.91

Ready to Invest?
Talk to our investment specialist
Disclaimer:
By submitting this form I authorize Fincash.com to call/SMS/email me about its products and I accept the terms of Privacy Policy and Terms & Conditions.

GlaxoSmithkline Consumer Healthcare Ltd Fundamentals

Quarterly Results

Quarterly reports are issued by companies every three months. Most companies have a financial year-end of Mar. 31 and quarters that end on June 30, Sept. 30, Dec. 31 and March 31.

Standalone Figures in Rs. Crores

Dec 2016Mar 2017Jun 2017Sep 2017Dec 2017Mar 2018Jun 2018Sep 2018Dec 2018Mar 2019Jun 2019Sep 2019
Sales8601,1039861,1121,0391,1801,1071,2721,1171,2861,1941,345
YOY Sales Growth %-11.46%2.36%4.45%2.91%20.8%6.96%12.3%14.42%7.45%9.03%7.87%5.75%
Expenses693885819853832930877918878968914949
Material Cost %32.21%34.13%34.75%35.44%31.01%31.68%30.43%30.34%29.29%30.04%30.04%29.33%
Employee Cost %12.4%9.28%13.57%11.44%12.68%11.66%15.17%12.19%14.03%12.82%15.43%11.84%
Operating Profit168218167259208250230354239318280396
OPM %19%20%17%23%20%21%21%28%21%25%23%29%
Other Income567055576184968912412312778
Interest111101000022
Depreciation171817181515151516152020
Profit before tax206269204298253319312427347426386452
Tax %34%35%35%35%35%34%36%36%36%33%36%24%
Net Profit136176132192164212200275221286248345
EPS in Rs32.4341.8231.4445.7538.9150.3647.6665.5052.5667.9558.9882.10
NotesNotesNotesNotesNotesNotesNotesNotesNotesNotesNotesNotes

Profit & Loss

The profit and loss (P&L) statement is a financial statement that summarizes the revenues, costs and expenses incurred during a specified period, usually a fiscal quarter or year. The P&L statement is synonymous with the income statement. These records provide information about a company's ability or inability to generate profit" by increasing revenue, reducing costs or both. Some refer to the P&L statement as a statement of profit and loss, income statement, statement of operations, statement of financial results or income, earnings statement or expense statement.

Standalone Figures in Rs. Crores

Dec 2007Dec 2008Dec 2009Dec 2010Dec 2011Dec 2012Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019TTM
Sales1,2741,5421,9212,3062,7653,1874,8694,3084,1363,9914,3174,7824,942
Sales Growth %14.93%21.06%24.62%20.01%19.93%15.28%52.74%-11.52%-3.98%-3.51%8.15%10.78%%
Expenses1,0491,3061,6111,9292,2612,6143,9963,5693,2983,1533,4333,6413,709
Material Cost %25.15%27.56%28.32%29.14%28.51%28.55%28.3%34.8%32.48%26.4%27.29%24.03%%
Manufacturing Cost %17.26%18.77%15.72%14.94%14.4%14.18%13.81%6.45%3.09%9.25%8.8%8.74%%
Employee Cost %11.78%10.8%10.1%9.62%9.34%9.45%9.65%10.01%12.21%11.3%12.23%13.48%%
Other Cost %28.16%27.57%29.7%29.96%29.5%29.84%30.31%31.6%31.95%32.06%31.22%29.9%%
Operating Profit2252363113775045738737388388388831,1411,233
OPM %18%15%16%16%18%18%18%17%20%21%20%24%25%
Other Income68958911785114207214278239257433452
Interest5543321123214
Depreciation43424240463663625764646071
Profit before tax2452843544525406491,0168891,0561,0101,0741,5121,610
Tax %34%34%34%34%34%33%34%34%35%35%35%35%
Net Profit1631882333003554376755846876577009831,100
EPS in Rs36.6442.2352.2962.9978.7896.55122.24127.57163.42156.15166.47233.69261.59
Dividend Payout %31%34%33%70%41%43%28%40%43%45%45%45%

Compounded Sales Growth

  • 10 Years:: 11.99%
  • 5 Years:: -0.36%
  • 3 Years:: 4.95%
  • TTM:: 7.49%

Compounded Profit Growth

  • 10 Years:: 18.05%
  • 5 Years:: 7.80%
  • 3 Years:: 12.69%
  • TTM:: 29.23%

Return on Equity

  • 10 Years:: 20.20%
  • 5 Years:: 8.91%
  • 3 Years:: 19.87%
  • 1 Year:: 21.72%

Balance Sheet

A balance sheet is a financial statement that reports a company's assets, liabilities and shareholders' equity at a specific point in time, and provides a basis for computing rates of return and evaluating its capital structure. It is a financial statement that provides a snapshot of what a company owns and owes, as well as the amount invested by shareholders. It is used alongside other important financial statements such as the income statement and statement of cash flows in conducting fundamental analysis or calculating financial ratios.

Standalone Figures in Rs. Crores

Dec 2007Dec 2008Dec 2009Dec 2010Dec 2011Dec 2012Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Sep 2019
Share Capital42424242424242424242424242
Equity Capital42.0642.0642.0642.0642.0642.0642.0642.0642.0642.0642.0642.0642.06
Reserves6047198639181,1021,3191,7712,0712,7573,0813,4434,0534,120
Borrowings00000000138000
Other Liabilities2723305248129461,2001,6151,9251,6991,8501,9542,0021,981
Trade Payables143.93172.46285356.92389.93500.32686.75781.67803.28898.621022.32963.95836.46
Total Liabilities9181,0911,4291,7722,0902,5613,4284,0384,5104,9815,4396,0976,143
Fixed Assets226210194202201194340492481487476462503
Gross Block523.67539.47558.48598.96636.66656.24854.621059.28569.43629.35650.85696.76
Accumulated Depreciation297.65329.24364396.71435.97462.4514.71567.5488.16141.93175.32234.69
CWIP17163810814919738425158381815
Investments298000000000000
Other Assets3778651,1971,4611,7412,1703,0503,5043,9774,4364,9265,6175,625
Inventories194.82277.17266.03312369.96369.64407.42466.25461.62461.14409.42465.47422.35
Trade receivables27.3643.2531.3650.3799.19112.61299.35313.36354.16321278.72385.68399.34
Cash Equivalents93.67470.98819.8976.11079.661464.241838.782296.522712.273087.383585.24097.344228.72
Loans n Advances61.3673.6179.56122.92141.28164.93315.23351.72357.38423.42430.75461.5349.87
Other Assets etc000050.4358.9188.8775.7591.91142.66221.42206.96524.26
Total Assets9181,0911,4291,7722,0902,5613,4284,0384,5104,9815,4396,0976,143

Cash Flows

Cash flow is the net amount of cash and cash-equivalents being transferred into and out of a business. At the most fundamental level, a company’s ability to create value for shareholders is determined by its ability to generate positive cash flows, or more specifically, maximize long-term free cash flow.

Standalone Figures in Rs. Crores

Dec 2007Dec 2008Dec 2009Dec 2010Dec 2011Dec 2012Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019
Cash from Operating Activity188135400326391554644611573603723671
Profit from operations266.69295.94371.06446.91526.97592.86914.15787.34872.06899.08929.771169.21
Working Capital Changes-13.57-57.12168.773944.69185.6763.23120.1353.4124.06260.211.38
Taxes paid-65.06-104.1-139.84-159.7-180.93-224.21-332.88-296-352-420.16-466.94-499.51
Cash from Investing Activity-2119-22-79-125-377-271331-152-602-446-335
Fixed Assets Purchased-25.47-30.71-46.29-114.3-97.8-83.74-168.59-107.43-54.53-68.29-51.39-33.96
Fixed Assets Sold0.281.391.025.672.551.861.081.772.42.571.991.3
Investments purchased-2000000000000
Investments sold022.290000000000
Cash from Financing Activity-63-55-30-91-248-175-223-222-286-361-363-377
Interest Paid-4.28-5.36-4.77-2.45-2.86-4.4-1.29-0.74-2.28-2.78-2.03-0.78
Dividends Paid-50.4-42.06-21.25-75.5-210.28-147.19-189.25-189.25-231.31-294.23-293.09-311.18
Net Cash Flow10499349156172150720136-361-87-41

Ready to Invest?
Talk to our investment specialist
Disclaimer:
By submitting this form I authorize Fincash.com to call/SMS/email me about its products and I accept the terms of Privacy Policy and Terms & Conditions.

Ratios

Dec 2007Dec 2008Dec 2009Dec 2010Dec 2011Dec 2012Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019
ROCE %42%41%43%48%52%52%64%46%43%34%33%40%
Debtor Days810681313222731292429
Inventory Turnover7.486.537.077.988.118.6212.539.868.928.659.9210.93

Announcements & News

Recent Announcements

Annual Reports

How to Invest in Mutual Funds SIP Online?

  1. Open Free Investment Account for Lifetime at Fincash.com.
  2. Complete your Registration and KYC Process
  3. Upload Documents (PAN, Aadhaar, etc.). And, You are Ready to Invest! Get Started
  4. Invest in Mutual Funds which invests in GlaxoSmithkline Consumer Healthcare Ltd & Get More Returns than Bank Deposit

Disclaimer:
All efforts have been made to ensure the information provided here is accurate as per time to time filling by company to exchanges. However, no guarantees are made regarding correctness of data. Investors are advised to validate/check information with exchanges or companies website before making any investment decisions.